(ASLN) Aslan Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Aslan Pharmaceuticals | (ASLN) share price targets
Complete technical analysis of Aslan Pharmaceuticals (ASLN) by charts plus indicators, forecast predictions and share price targets for Aslan Pharmaceuticals (ASLN)
Aslan Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-02-29 View latest technical analysis
10 day averaged volume of Aslan Pharmaceuticals is 212970
Date | Daily Closing Price | Open | High | Low | Volume |
29 Thu Feb 2024 | 0.88 | 0.72 | 0.90 | 0.68 | 3.843 times |
28 Wed Feb 2024 | 0.70 | 0.49 | 0.71 | 0.48 | 3.688 times |
27 Tue Feb 2024 | 0.47 | 0.42 | 0.48 | 0.42 | 0.454 times |
26 Mon Feb 2024 | 0.42 | 0.42 | 0.44 | 0.41 | 0.877 times |
23 Fri Feb 2024 | 0.41 | 0.43 | 0.46 | 0.40 | 0.794 times |
22 Thu Feb 2024 | 0.41 | 0.47 | 0.50 | 0.40 | 0.972 times |
21 Wed Feb 2024 | 0.47 | 0.53 | 0.53 | 0.47 | 0.967 times |
20 Tue Feb 2024 | 0.52 | 0.51 | 0.54 | 0.50 | 0.447 times |
16 Fri Feb 2024 | 0.52 | 0.56 | 0.56 | 0.50 | 1.049 times |
15 Thu Feb 2024 | 0.56 | 0.57 | 0.57 | 0.53 | 0.506 times |
Stock of Aslan Pharmaceuticals (ASLN) has showed a significant upmove. This could be a good time to enter in this stock!
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 0.8, for a target of 0.7 or 0.55
Share price targets for Aslan Pharmaceuticals (ASLN)
Target Type | Value |
Downside Target | 0.39 |
Downside Target | 0.40 |
Downside Target | 0.41 |
Downside Target | 0.46 |
Downside Target | 0.47 |
Downside Target | 0.50 |
Downside Target | 0.53 |
Downside Target | 0.57 |
Downside Target | 0.59 |
Downside Target | 0.63 |
Downside Target | 0.70 |
Upside Target | 0.90 |
Upside Target | 0.95 |
Upside Target | 1.05 |
Upside Target | 1.20 |
Upside Target | 1.92 |
Intraday share price targets for Aslan Pharmaceuticals (ASLN)
Target Type | Value |
Downside Intraday Target | 0.56 |
Downside Intraday Target | 0.24 |
Upside Intraday Target | 1.05 |
Upside Intraday Target | 1.22 |
Downside Intraday Target | 0.73 |
Weekly technical analysis of Aslan Pharmaceuticals (ASLN)
Date | Weekly Closing Price | Open | High | Low | Volume |
29 Thu Feb 2024 | 0.88 | 0.42 | 0.90 | 0.41 | 2.787 times |
23 Fri Feb 2024 | 0.41 | 0.51 | 0.54 | 0.40 | 1.04 times |
16 Fri Feb 2024 | 0.52 | 0.53 | 0.57 | 0.50 | 0.594 times |
09 Fri Feb 2024 | 0.55 | 0.56 | 0.59 | 0.47 | 1.427 times |
02 Fri Feb 2024 | 0.58 | 0.60 | 0.70 | 0.53 | 1.757 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Aslan Pharmaceuticals (ASLN)
Date | Monthly Closing Price | Open | High | Low | Volume |
29 Thu Feb 2024 | 0.88 | 0.69 | 0.90 | 0.40 | 1.215 times |
31 Wed Jan 2024 | 0.68 | 0.52 | 0.95 | 0.46 | 0.593 times |
29 Fri Dec 2023 | 0.52 | 0.69 | 0.71 | 0.39 | 6.826 times |
30 Thu Nov 2023 | 0.69 | 1.13 | 1.20 | 0.63 | 1.236 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Aslan Pharmaceuticals (ASLN)
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Aslan Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Aslan Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Aslan Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Aslan Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aslan Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.65 and Aslan Pharmaceuticals (ASLN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Aslan Pharmaceuticals (ASLN) stock. Volume based technical analysis of Aslan Pharmaceuticals (ASLN) stock is negative.
Aslan Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Aslan Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Aslan Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Aslan Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Aslan Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aslan Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.65 and Aslan Pharmaceuticals (ASLN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Aslan Pharmaceuticals (ASLN) stock. Volume based technical analysis of Aslan Pharmaceuticals (ASLN) stock is negative.
Aslan Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.